ZBH लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (8 May 2024 @ 01:30):

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific...

Stats
आज की मात्रा	1.27M
औसत मात्रा	1.41M
बाजार मूल्य	25.35B
EPS	$0 ( 2024-04-30 )
अगली कमाई की तारीख	( $1.870 ) 2024-05-10
Last Dividend	$0.240 ( 2023-09-28 )
Next Dividend	$0 ( N/A )
P/E	56.74
ATR14	$0.0650 (0.05%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Winkler Lori	Buy	772	Common Stock
2024-04-01	Winkler Lori	Sell	215	Common Stock
2024-04-01	Winkler Lori	Sell	772	Restricted Stock Units
2024-03-31	Michelson Michael W	Buy	207	Phantom Stock Units
2024-03-31	Hilado Maria Teresa	Buy	207	Phantom Stock Units

INSIDER POWER
10.08
Last 99 transactions
Buy: 197 885 \| Sell: 163 900

मात्रा सहसंबंध

लंबा: 0.66 (moderate)

छोटा: 0.80 (strong)

Signal:(52.609) Same movement expected

Zimmer Biomet Holdings सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Zimmer Biomet Holdings सहसंबंध - मुद्रा/वस्त्र

0.36
( neutral )

0.64
( weak )

0.00
( neutral )

0.59
( weak )

0.15
( neutral )

0.52
( weak )

Zimmer Biomet Holdings वित्तीय

Annual	2023
राजस्व:	$7.39B
सकल लाभ:	$4.66B (63.06 %)
EPS:	$4.91

FY	2023
राजस्व:	$7.39B
सकल लाभ:	$4.66B (63.06 %)
EPS:	$4.91

FY	2022
राजस्व:	$6.94B
सकल लाभ:	$4.92B (70.90 %)
EPS:	$1.390

FY	2021
राजस्व:	$7.84B
सकल लाभ:	$5.50B (70.13 %)
EPS:	$1.930

Financial Reports:

No articles found.

Zimmer Biomet Holdings Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.240 (N/A)	$0.240 (N/A)	$0.240 (N/A)	$0.480 (N/A)	$0.240 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Zimmer Biomet Holdings Dividend Information - Dividend Knight

Dividend Sustainability Score: 9.49 - good (94.94%) | Divividend Growth Potential Score: 3.69 - Decrease likely (26.18%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.175	2012-03-28
Last Dividend	$0.240	2023-09-28
Next Dividend	$0	N/A
Payout Date	2023-10-31
Next Payout Date	N/A
# dividends	48	--
Total Paid Out	$10.70	--
Avg. Dividend % Per Year	0.48%	--
Score	4.15	--
Div. Sustainability Score	9.49
Div.Growth Potential Score	3.69
Div. Directional Score	6.59	--

Next Divdend (Est)
(2024-07-01)

$0.244 Estimate 22.50 %

Dividend Stability

0.60 Above Average

Dividend Score

4.15

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2012	$0.700	1.34%
2013	$0.776	1.18%
2014	$0.856	0.96%
2015	$0.856	0.78%
2016	$0.932	0.94%
2017	$0.932	0.93%
2018	$0.932	0.77%
2019	$0.932	0.94%
2020	$0.932	0.64%
2021	$0.932	0.63%
2022	$0.960	0.77%
2023	$0.960	0.75%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50
ZTR	Dividend Royal	2024-02-09	Monthly	37	8.35%	8.50
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.138	1.500	7.23	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0476	1.200	8.41	10.00	[0 - 0.3]
returnOnEquityTTM	0.0827	1.500	-0.192	-0.289	[0.1 - 1]
payoutRatioTTM	0.196	-1.000	8.04	-8.04	[0 - 1]
currentRatioTTM	1.613	0.800	6.93	5.55	[1 - 3]
quickRatioTTM	0.650	0.800	-0.881	-0.704	[0.8 - 2.5]
cashRatioTTM	0.146	1.500	-0.303	-0.454	[0.2 - 2]
debtRatioTTM	0.271	-1.500	5.49	-8.23	[0 - 0.6]
interestCoverageTTM	6.75	1.000	8.61	8.61	[3 - 30]
operatingCashFlowPerShareTTM	7.58	2.00	7.47	10.00	[0 - 30]
freeCashFlowPerShareTTM	5.39	2.00	7.30	10.00	[0 - 20]
debtEquityRatioTTM	0.466	-1.500	8.13	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.718	1.000	1.363	1.363	[0.2 - 0.8]
operatingProfitMarginTTM	0.184	1.000	8.33	8.33	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.272	1.000	9.60	9.60	[0.2 - 2]
assetTurnoverTTM	0.344	0.800	-1.040	-0.832	[0.5 - 2]
Total Score				9.49

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	24.56	1.000	7.62	0	[1 - 100]
returnOnEquityTTM	0.0827	2.50	-0.124	-0.289	[0.1 - 1.5]
freeCashFlowPerShareTTM	5.39	2.00	8.20	10.00	[0 - 30]
dividendYielPercentageTTM	0.398	1.500	0.0465	0	[0 - 0.4]
operatingCashFlowPerShareTTM	7.58	2.00	7.47	10.00	[0 - 30]
payoutRatioTTM	0.196	1.500	8.04	-8.04	[0 - 1]
pegRatioTTM	-0.262	1.500	-5.08	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.214	1.000	7.15	0	[0.1 - 0.5]
Total Score				3.69

Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

के लिए वास्तविक समय के अद्यतन Zimmer Biomet Holdings [ZBH]

Upcoming Earnings Alert

Zimmer Biomet Holdings Dividend Information - Dividend Knight

Dividend Commentary

Top 10 dividend Companies for NYSE

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)